
Mengchen ZHANG. MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2500281 @article{title="MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation", %0 Journal Article TY - JOUR
高原鼢鼠MDM2/X参与下调细胞凋亡:一种独特的高原适应机制1浙江大学医学院第二附属医院神经内科, 脑科学与脑医学学院, 中国杭州, 310016 2浙江大学医学院国家卫生健康委员会和中国医学科学院重点实验室, 中国杭州, 310058 3浙江大学基础医学院生理学系和第一附属医院肝胆胰外科, 中国杭州, 310058 4兰州大学生态学创新研究院, 草种创新与草地农业生态系统全国重点实验室, 中国兰州, 730000 5桂林医科大学人工智能医学院, 中国桂林, 541004 6海法大学进化研究所, 以色列海法, 31905 摘要:小鼠双微体2(MDM2)与小鼠双微体4(MDMX)是调控p53功能和细胞凋亡的关键因子。本研究通过系统比较分布在青藏高原和黄土高原地下鼢鼠的Mdm2/x基因序列和功能变异位点,结果发现Mdm2/x变异位点介导高海拔极端环境(低氧、低温和黑暗)的分子适应机制。本研究克隆并分析了两个不同生态环境下的地下啮齿动物-高原鼢鼠(Myospalax baileyi)和甘肃鼢鼠(Myospalax cansus)的Mdm2/x基因序列,并构建了包括啮齿动物和哺乳动物(地上、地下),以及实验室大鼠和人类(地上)的系统发育树。结果显示,M. baileyi和M. cansus的MDM2/X以依赖p53的方式参与低凋亡率过程;而位于MDM2的C端磷酸化变异位点有助于p53转录和蛋白质水平的表达上调。本研究揭示基因的演化机制赋予了生物在极端胁迫条件下的生存能力,并为阐述极具挑战的地球生态系统中土著动物的基因变异如何驱动生理功能韧性提供了重要科学证据。 关键词组: Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]An X, Mao LY, Wang YJ, et al., 2024. Genomic structural variation is associated with hypoxia adaptation in high-altitude zokors. Nat Ecol Evol, 8(2):339-351. [2]Anil B, Riedinger C, Endicott JA, et al., 2013. The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant. Acta Crystallogr D Biol Crystallogr, 69(8):1358-1366. [3]Ashur-Fabian O, Avivi A, Trakhtenbrot L, et al., 2004. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation. Proc Natl Acad Sci USA, 101(33):12236-12241. [4]Brummer T, Zeiser R, 2024. The role of the MDM2/p53 axis in antitumor immune responses. Blood, 143(26):2701-2709. [5]Cai ZY, Wang LY, Song XY, et al., 2018. Adaptive transcriptome profiling of subterranean zokor, Myospalax baileyi, to high-altitude stresses in Tibet. Sci Rep, 8:4671. [6]Cao WJ, Pu P, Wang JZ, et al., 2020. Suppressed LPS-mediated TLR4 signaling in the plateau zokor (Eospalax baileyi) compared to the bamboo rat (Rhizomys pruinosus) and rat (Rattus norvegicus). J Exp Zool Part A Ecol Integr Physiol, 333(4):240-251. [7]Carr MI, Roderick JE, Zhang H, et al., 2016. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice. Proc Natl Acad Sci USA, 113(52):15024-15029. [8]Chandramohan A, Josien H, Yuen TY, et al., 2024. Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists. Nat Commun, 15:489. [9]Chen LH, Gilkes DM, Pan Y, et al., 2005. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J, 24(19):3411-3422. [10]Chen XQ, Wang SJ, Du JZ, et al., 2007. Diversities in hepatic HIF-1, IGF-I/IGFBP-1, LDH/ICD, and their mRNA expressions induced by CoCl2 in Qinghai-Tibetan plateau mammals and sea level mice. Am J Physiol Regul Integr Comp Physiol, 292(1):R516-R526. [11]Cheng Q, Chen LH, Li ZY, et al., 2009. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J, 28(24):3857-3867. [12]Cheng Q, Cross B, Li BZ, et al., 2011. Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage. Mol Cell Biol, 31(24):4951-4963. [13]Chibaya L, Karim B, Zhang H, et al., 2021. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci USA, 118(4):e2003193118. [14]Coffill CR, Lee AP, Siau JW, et al., 2016. The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans. Genes Dev, 30(3):281-292. [15]Corpet F, 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res, 16(22):10881-10890. [16]Deng XG, Wang K, Zhang SD, et al., 2014. Transcriptomatic determination of convergent evolution between plateau zokors (Eospalax baileyi) and naked mole rats (Heterocephalus glaber). Acta Theriol Sin, 34(2):129-137 (in Chinese). [17]Efe G, Rustgi AK, Prives C, 2024. p53 at the crossroads of tumor immunity. Nat Cancer, 5(7):983-995. [18]Fang Y, Liao GC, Yu B, 2020. Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives. Acta Pharm Sin B, 10(7):1253-1278. [19]Gajjar M, Candeias MM, Malbert-Colas L, et al., 2012. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell, 21:25-35. [20]Gan Y, Wu YJ, Dong YQ, et al., 2023. The study on the impact of sex on the structure of gut microbiota of bamboo rats in China. Front Microbiol, 14:1276620. [21]Gannon HS, Woda BA, Jones SN, 2012. ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell, 21(5):668-679. [22]Gao CH, Li JM, Xu B, et al., 2023. Responses of blood parameters and hemoglobin subtypes in plateau zokors and plateau pikas to different altitude habitats. Acta Physiol Sin, 75(1):69-81 (in Chinese). [23]Goldberg Z, Vogt Sionov R, Berger M, et al., 2002. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J, 21(14):3715-3727. [24]Gorbunova V, Hine C, Tian X, et al., 2012. Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Proc Natl Acad Sci USA, 109(47):19392-19396. [25]Guo YT, Zhang J, Xu DM, et al., 2021. Phylogenomic relationships and molecular convergences to subterranean life in rodent family Spalacidae. Zool Res, 42(5):671-674. [26]Hashimoto T, Murata Y, Urushihara Y, et al., 2018. Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways. Biochem Biophys Res Commun, 505(1):13-19. [27]Holehouse AS, Kragelund BB, 2024. The molecular basis for cellular function of intrinsically disordered protein regions. Nat Rev Mol Cell Biol, 25(3):187-211. [28]Hu YB, Wang XP, Xu YC, et al., 2023. Molecular mechanisms of adaptive evolution in wild animals and plants. Sci China Life Sci, 66(3):453-495. [29]Karakostis K, Malbert-Colas L, Thermou A, et al., 2024. The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway. Mol Cancer, 23:21. [30]Levine AJ, 2020. p53:800 million years of evolution and 40 years of discovery. Nat Rev Cancer, 20:471-480. [31]Liu X, Zhang SZ, Cai ZY, et al., 2022. Genomic insights into zokors’ phylogeny and speciation in China. Proc Natl Acad Sci USA, 119(19):e2121819119. [32]Medina-Medina I, García-Beltrán P, de la Mora-de la Mora I, et al., 2016. Allosteric interactions by p53 mRNA govern HDM2 E3 ubiquitin ligase specificity under different conditions. Mol Cell Biol, 36(16):2195-2205. [33]Olcina MM, Grand RJ, Hammond EM, 2014. ATM activation in hypoxia - causes and consequences. Mol Cell Oncol, 1(1):e29903. [34]Oren M, Prives C, 2024. p53: a tale of complexity and context. Cell, 187(7):1569-1573. [35]Padariya M, Jooste ML, Hupp T, et al., 2022. The elephant evolved p53 isoforms that escape MDM2-mediated repression and cancer. Mol Biol Evol, 39(7):msac149. [36]Pant V, Lozano G, 2014. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev, 28(16):1739-1751. [37]Peuget S, Zhou XL, Selivanova G, 2024. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer, 24:192-215. [38]Shao Y, Li JX, Ge RL, et al., 2015. Genetic adaptations of the plateau zokor in high-elevation burrows. Sci Rep, 5:17262. [39]Shi Y, Liu Z, Zhang Q, et al., 2020. Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis. PLoS Biol, 18(12):e3000991. [40]Tan BX, Liew HP, Chua JS, et al., 2017. Anatomy of Mdm2 and Mdm4 in evolution. J Mol Cell Biol, 9(1):3-15. [41]Tuval A, Strandgren C, Heldin A, et al., 2024. Pharmacological reactivation of p53 in the era of precision anticancer medicine. Nat Rev Clin Oncol, 21:106-120. [42]Wang C, Zhang YJ, Chen WJ, et al., 2024. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer, 23:110. [43]Wang W, Albadari N, Du Y, et al., 2024. MDM2 inhibitors for cancer therapy: the past, present, and future. Pharmacol Rev, 76(3):414-453. [44]Wei DB, Wei L, Zhang JM, et al., 2006. Blood-gas properties of plateau zokor (Myospalax baileyi). Comp Biochem Physiol Part A Mol Integr Physiol, 145(3):372-375. [45]Wei YY, Zhang T, Li ZF, et al., 2025. Evolutionary divergence on the Qinghai–Xizang Plateau: how life-history traits shape the diversity of plateau zokor and pika populations. J Genet Genomics, 52(9):1096-1108. [46]Wu KKL, Xu XF, Wu MY, et al., 2024. MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice. Nat Commun, 15:8624. [47]Xiao KP, Liang XH, Lu HR, et al., 2022. Adaptation of gut microbiome and host metabolic systems to lignocellulosic degradation in bamboo rats. ISME J, 16(8):1980-1992. [48]Yu ZQ, Zhang EE, 2023. Disrupted circadian rhythms in the plateau pika. Trends Neurosci, 46(12):1005-1007. [49]Zhang NY, Hou DY, Hu XJ, et al., 2023. Nano proteolysis targeting chimeras (PROTACs) with anti-hook effect for tumor therapy. Angew Chem Int Ed, 62(37):e202308049. [50]Zhang ST, Zhao Y, Hu XF, et al., 2013. Distinct post-transcriptional regulation of Igfbp1 gene by hypoxia in lowland mouse and Qinghai-Tibet plateau root vole Microtus oeconomus. Mol Cell Endocrinol, 376(1-2):33-42. [51]Zhang T, Lei ML, Zhou H, et al., 2022. Phylogenetic relationships of the zokor genus Eospalax (Mammalia, Rodentia, Spalacidae) inferred from whole-genome analyses, with description of a new species endemic to Hengduan Mountains. Zool Res, 43(3):331-342. [52]Zhang XY, Khakisahneh S, Liu W, et al., 2023. Phylogenetic signal in gut microbial community rather than in rodent metabolic traits. Natl Sci Rev, 10:nwad209. [53]Zhao Y, Ren JL, Wang MY, et al., 2013. Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau. Proc Natl Acad Sci USA, 110(51):20639-20644. [54]Zhao Y, Tang JW, Yang Z, et al., 2016. Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, Spalax. Proc Natl Acad Sci USA, 113(8):2146-2151. CLC number: On-line Access: 2026-10-23 Received: 2025-05-27 Revision Accepted: 2025-09-10 Crosschecked: 0000-00-00 Cited: 0 Clicked: 3444 Citations: Bibtex RefMan EndNote GB/T7714 Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2026 Journal of Zhejiang University-SCIENCE | ||||||||||||||
Open peer comments: Debate/Discuss/Question/Opinion
<1>